Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page
- CheckyesterdayChange DetectedNew revision entry v3.6.3 has been added and the previous v3.6.2 version removed in the study’s record history. This is a minor metadata update and does not affect study content or user-facing information.SummaryDifference0.1%

- Check8 days agoChange DetectedThe record history gains a new revision entry for v3.6.2 and removes the older v3.6.0 entry. This reflects an administrative update to the history log.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRecruitment status updated to no longer looking for participants, indicating the study is not enrolling at this time. A new version 3.6.0 was posted and the older version 3.5.5 was removed from the history.SummaryDifference0.5%

- Check30 days agoChange DetectedA new revision entry (v3.5.5) was added to the record history. This indicates the study record was updated after the previous version.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry labeled v3.5.4 has been added to the study record history, replacing the prior v3.5.3 entry. This reflects an updated version of the ClinicalTrials.gov page as part of a maintenance release.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision history now shows a new revision tag, v3.5.3, replacing the previous v3.5.2. This indicates a metadata/version update to the page rather than changes to the study information.SummaryDifference0.1%

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.